$ARQQ

Leaver Andrew sold $60K of ARQQ

Leaver Andrew (Chief Executive Officer) sold 2,535 shares of Arqit Quantum Inc. (ARQQ) at $23.78 on 2026-10-05.

Original reporting
SEC EDGAR · Leaver Andrew
Published Oct 7, 2026, 11:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Bearish
medium confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQBearishLow
01

Why it matters

The disclosed sale is the first public report of this transaction, providing new data for market participants.

02

Market read

A small insider sale by the CEO may cause modest short-term price pressure but is unlikely to drive major market moves.

03

What to watch

The CEO retains a sizable stake of 56,547 shares, maintaining confidence in the company.

Relevance 3/10Novelty 3/10Timing: after-hours filing on Oct 7, 2026

Background

Form 4 filings disclose insider transactions and are used by traders to gauge potential sentiment shifts.

Company-level read

Ticker impact

$ARQQBearishMedium confidence
Context

CEO Leaver Andrew sold 2,535 shares for $60,294 in an open-market transaction filed on Oct 7, 2026.

Expected impact

likely modest downward pressure as the market prices the insider sell.

Evidence & confidence

A $60k sale by the CEO is a primary disclosure but the amount is small relative to the company's market cap, suggesting limited impact.

Market effects

Minimal effect on the quantum technology sector.

No significant regional impact.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity move and not indicative of any negative outlook.

Key entities

  • Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ARQQ.

  • Leaver Andrew

    Chief Executive Officer of Arqit Quantum Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).